Search - Prime Therapeutics - Portal

457 Results for GLP-1 Pipeline Update

Business Insider: Inside your company's struggle over whether to pay for hot, new weight-loss drugs

Business Insider

PA Sub-Categories: GLP-1 Prime Article: In the News
Endpoint News: Almost all patients quit weight loss shots within two years, analysis finds

Endpoint News

PA Sub-Categories: GLP-1 Prime Article: In the News
Reuters: Exclusive: Most patients using weight-loss drugs like Wegovy stop within a year, data show

Reuters

PA Sub-Categories: GLP-1 Prime Article: In the News
Reuters: Exclusive: Most patients stop using Wegovy, Ozempic for weight loss within two years

Reuters

PA Sub-Categories: GLP-1 Prime Article: In the News

Page 1
- Page 2
- Page 3
- Page 4
- Page 5
- Page 6
- Page 7
- Page 8
- Page 9
- Page 10
- Page 11
- Page 12
- Page 13
- Page 14
- Page 15
- Page 16
- Page 17
- Page 18
- Page 19
Page 49
Page 50
Page 51
- Page 52
- Page 53
- Page 54
- Page 55
- Page 56
- Page 57
- Page 58
- Page 59
- Page 60
- Page 61
- Page 62
- Page 63
- Page 64
- Page 65
- Page 66
- Page 67
- Page 68
- Page 69
- Page 70
- Page 71
Page 115

Login Portals

Compliance / Legal

Company

© 2025 Prime Therapeutics LLC